Salih AKOLUK
(Tutak İlçe Devlet Hastanesi, Ağrı İl Sağlık Müdürlüğü, Hemşirelik Bölümü, Ağrı, Türkiye)
Nimet OVAYOLU
(Sanko Üniversitesi, Sağlık Bilimleri Fakültesi, İç Hastalıkları Hemşireliği Anabilim Dalı, Gaziantep, Türkiye)
Yıl: 2021Cilt: 27Sayı: 1ISSN: 1300-7157Sayfa Aralığı: 8 - 14Türkçe

84 0
Compliance of Patients with Epilepsy toTreatment and Affecting Factors
Objectives: Ensuring patient compliance in the treatment of epilepsy is crucial for the treatment success. Therefore, this study was performed to evaluate the compliance of patients with epilepsy to therapy.Methods: A total of 325 patients diagnosed with epilepsy after admission to the polyclinic were included in the study. A questionnaire and the Morisky treatment compliance scale were used for data collection. Data were analyzed using the Pearson chi-square and Fisher’s exact tests.Results: In this study, 58.2% of the patients were males, 28.5% were university graduates, 32.4% were unemployed, 40.6% were using single drugs, and 31.4% of them had disease duration of >10 years. It was determined that 82.5% of the patients went for regular checkups, and 59.7% of them had a seizure frequency of <1 seizure per month. Additionally, in terms of treatment compliance, 27.7% of the patients were high, 58.5% were moderate, and 13.8% were low. Furthermore, there was a significant difference in the level of compliance to treatment according to age, gender, education and income status, place of residence, occupation, number of drugs used, information about the drug, and the state of the drug being measured.Conclusion: It was determined that the majority of patients with epilepsy had a moderate treatment compliance and that there was a relation-ship between the level of treatment compliance and many parameters. In line with these results, it may be recommended to evaluate patients’ compliance levels and factors affecting compliance at certain intervals and to especially support patients with low compliance levels.
DergiAraştırma MakalesiErişime Açık
  • 1. Bora Hİ, Yeni SN, Gürses C. Epilepsi. 1st ed, İstanbul: Nobel Tıp Kitabevleri; 2008. p. 707−34.
  • 2. Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology 2017;88(3):296–303.
  • 3. Yavuz V, baykan B. Epilepsi Tedavisinde Güncel Yaklaşımlar. Klinik Gelişim Dergisi 2015;6(1):39–43.
  • 4. Eşkazan E ÖÇ, Özyurt E. Epilepsilerde Tanı ve Tedavi. İstanbul: Güncel Tıp Yayınları; 1998.
  • 5. Mısırlı H. Quality of life for patients with epilepsy. Journal of the Turkish Chapter of ILAE. 2003;9(1):42–6.
  • 6. Rowland LP, Mazzoni P, Pearson TS. Merrit’s Neurology. 2nd ed., Güneş Tıp Kitabevleri; İstanbul. 2009.
  • 7. Gulay B, Kendirli MT, Demir S, Sonkaya AR, Ozdag MF. Epilepsi hastalarında ilaç tedavisine uyumun yaşam kalitesi üzerine etkileri. Epilepsi 2018;24(1):8–14.
  • 8. Şenol MG, İlknur G, Toğrol E, Olgun N, Saraçoğlu M. Epilepsi hastalarında antiepileptik ilaç tedavisine uyumu etkileyen etmenler. Düzce Tıp Fakültesi Dergisi 2009;11(1):21–31.
  • 9. Yılmaz S, Buzlu S. Antipsikotik kullanan hastalarda ilaç yan etkileri ve ilaç uyumu. Florence Nightingale Hemşirelik Dergisi 2012;20(2):93–103.
  • 10. Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet 2012;380(9848):1193–201.
  • 11. Li X, Sundquist J, Sundquist K. Socioeconomic and occupational risk factors for epilepsy: a nationwide epidemiological study in Sweden. Seizure 2008;17(3):254–60.
  • 12. Coşar DA. Epilepsili hastalarda yaşam kalitesi ve etkileyen faktörlerin incelenmesi. Yüksek Lisans Tezi. Erzurum: Atatürk Üniversitesi, Sağlık Bilimleri Enstitüsü; 2016.
  • 13. Elliott JO, Charyton C, Sprangers P, Lu B, Moore JL. The impact of marriage and social support on persons with active epilepsy. Epilepsy Behav 2011;20(3):533–8.
  • 14. Hamedi-Shahraki S, Eshraghian MR, Yekaninejad MS, Nikoobakht M, Rasekhi A, Chen H, et al. Health-related quality of life and medication adherence in elderly patients with epilepsy. Neurol Neurochir Pol 2019;53(2):123–30.
  • 15. Malek N, Heath CA, Greene J. A review of medication adherence in people with epilepsy. Acta Neurol Scand 2017;135(5):507–15.
  • 16. Gollwitzer S, Kostev K, Hagge M, Lang J, Graf W, Hamer HM. Nonadherence to antiepileptic drugs in Germany: A retrospective, population-based study. Neurology 2016;87(5):466–72.
  • 17. Neni SW, Latif AZ, Wong SY, Lua PL. Awareness, knowledge and attitudes towards epilepsy among rural populations in East Coast Peninsular Malaysia: a preliminary exploration. Seizure 2010;19(5):280–90.
  • 18. Mushi D, Hunter E, Mtuya C, Mshana G, Aris E, Walker R. Social-cultural aspects of epilepsy in Kilimanjaro Region, Tanzania: knowledge and experience among patients and carers. Epilepsy Behav 2011;20(2):338–43.
  • 19. Ferrari CM, de Sousa RM, Castro LH. Factors associated with treatment non-adherence in patients with epilepsy in Brazil. Seizure 2013;22(5):384–9.
  • 20. Elsayed MA, El-Sayed NM, Badi S, Ahmed MH. Factors affecting adherence to antiepileptic medications among Sudanese individuals with epilepsy: A cross-sectional survey. J Family Med Prim Care 2019;8(7):2312–7.
  • 21. Aydemir N, Ünsal P, Özkara Ç. Epilepsisi olan bireylerin epilepsiye dair sahip oldukları tutum, bilgi ve bilgi kaynakları. Epilepsi 2011;17(3):90–6.
  • 22. Mameniskiene R, Sakalauskaite-Juodeikiene E, Budrys V. People with epilepsy lack knowledge about their disease. Epilepsy Behav 2015;46:192–7.
  • 23. England MJ, Liverman CT, Schultz AM, Strawbridge LM. Epilepsy across the spectrum: promoting health and understanding. A summary of the Institute of Medicine report. Epilepsy Behav 2012;25(2):266–76.
  • 24. Velioglu SK, Bakirdemir M, Can G, Topbas M. Prevalence of epilepsy in northeast Turkey. Epileptic Disord 2010;12(1):22–37.
  • 25. Degirmenci Y, Canbaz Kabay S, Yilmaz Z, Bakar C, Ozisik Karaman HI. Perception of epilepsy in Turkey in the light of two different cities. Acta Clinica Croatica 2013;52(1):59–66.
  • 26. Farrukh MJ, Bakry MM, Hatah E, Jan TH. Association between complementary and alternative medicines (CAM) usage and self-perceived cognitive impairment among epilepsy patients. Archives of Pharmacy Practice 2020;1:124.
  • 27. Kralj-Hans I, Goldstein LH, Noble AJ, Landau S, Magill N, McCrone P, et al. Self-Management education for adults with poorly controlled epILEpsy (SMILE (UK)): a randomised controlled trial protocol. BMC Neurol 2014;14:69.
  • 28. Bellon M, Pfeiffer W, Maurici V. Choice and control: how involved are people with epilepsy and their families in the management of their epilepsy? Results from an Australian survey in the disability sector. Epilepsy Behav 2014;37:227–32.
  • 29. Ninnoni JPK. A qualitative study of the communication and information needs of people with learning disabilities and epilepsy with physicians, nurses and carers. BMC Neurol 2019;19(1):12.
  • 30. O’ Rourke G, O’ Brien JJ. Identifying the barriers to antiepileptic drug adherence among adults with epilepsy. Seizure 2017;45:160–8.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.